Background Carcinoembryonic antigen (CEA) is one of the most widely used tumor markers
and is increased in 30%–60% of patients with pancreatic cancer. Although carbohydrate …

The tetrasaccharide structures Siaα2, 3Galβ1, 3 (Fucα1, 4) GlcNAc and Siaα2, 3Galβ1, 4
(Fucα1, 3) GlcNAc constitute the epitopes of the carbohydrate antigens sialyl-Lewis a (sLea) …

Purpose: It is suggested that tumour markers carcinoembryonic antigen (CEA) and
carbohydrate antigen 19-9 (CA19-9) could be used to predict the stage of pancreatic cancer …

Gastric cancer (GC) is the third most common cause of cancer-related death in the world,
representing a major global health issue. Although the incidence of GC is declining, the …

This study aimed to compare the changes and determine the clinical significance of
carbohydrate antigens CA242, CA199, CA125, carcinoembryonic antigen (CEA), and tumor …

Background Even when resectable pancreatic cancer (PC) is associated with a dismal
prognosis. Initial presentation varies according with primary tumor location. Aim of this …

Background Current guidelines for IPMN include an elevated serum carbohydrate antigen
(CA) 19-9 among the worrisome features. However, the correlation of CA 19-9 with …

Abstract Background Allogeneic blood transfusions (BTFs) are sometimes required for
radical gastrectomy with regional lymph node dissection for advanced gastric cancer (GC) …

The expression levels of one-carbon metabolic enzymes were investigated and observed to
be correlated with clinicopathological parameters in patients with pancreatic cancer …

OBJECTIVE: Gastric cancer is one of the most common cancers worldwide, and the
prognosis is still very poor due to the lack of specific and sensitive biomarkers. Aerobic …